DYN - Dyne Therapeutics

-

$undefined

N/A

(N/A)

Dyne Therapeutics NasdaqGS:DYN Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Location: 1560 Trapelo Road, Waltham, MA, 02451, United States | Website: https://www.dyne-tx.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

737.1M

Cash

677.5M

Avg Qtr Burn

-79.93M

Short % of Float

24.63%

Insider Ownership

0.69%

Institutional Own.

-

Qtr Updated

03/31/25